- March 12, 2021
- Category: Healthcare and LifeSciences, Medical Diagnostics
Global Newborn Screening Market Size study, by Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, DNA Assays, Other Technologies), by Test Type (Dried Blood Spot, Hearing Screening, Critical Congenital Heart Defect (CCHD), Other Test Types), by End user (Hospitals, Diagnostic Centers, Other End Users) and Regional Forecasts 2021-2027
Chapter 1.Executive Summary 1.1. Market Snapshot 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion) 1.2.1. Newborn Screening Market , by Region, 2019-2027 (USD Billion) 1.2.2. Newborn Screening Market , by Technology, 2019-2027 (USD Billion) 1.2.3. Newborn Screening Market , by Test Type, 2019-2027 (USD Billion) 1.2.4. Newborn Screening Market , by End user, 2019-2027 (USD Billion) 1.3. Key Trends 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Newborn Screening Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Scope of the Study 2.2.2. Industry Evolution 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Newborn Screening Market Dynamics 3.1. Newborn Screening Market Impact Analysis (2019-2027) 3.1.1. Market Drivers 220.127.116.11. Rising prevalence of newborn disorders 18.104.22.168. Favourable reimbursement policies 3.1.2. Market Restraint 22.214.171.124. Availability of refurbished products 3.1.3. Market Opportunities 126.96.36.199. Growth potential of emerging economies Chapter 4. Global Newborn Screening Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Suppliers 4.1.2. Bargaining Power of Buyers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027) 4.2. PEST Analysis 4.2.1. Political 4.2.2. Economical 4.2.3. Social 4.2.4. Technological 4.3. Investment Adoption Model 4.4. Analyst Recommendation & Conclusion Chapter 5. Global Newborn Screening Market , by Technology 5.1. Market Snapshot 5.2. Global Newborn Screening Market by Technology , Performance - Potential Analysis 5.3. Global Newborn Screening Market Estimates & Forecasts by Technology 2018-2027 (USD Billion) 5.4. Newborn Screening Market , Sub Segment Analysis 5.4.1. Tandem Mass Spectrometry 5.4.2. Pulse Oximetry 5.4.3. Enzyme Based Assays 5.4.4. DNA Assays 5.4.5. Other Technologies Chapter 6. Global Newborn Screening Market , by Test Type 6.1. Market Snapshot 6.2. Global Newborn Screening Market by Test Type, Performance - Potential Analysis 6.3. Global Newborn Screening Market Estimates & Forecasts by Test Type 2018-2027 (USD Billion) 6.4. Newborn Screening Market , Sub Segment Analysis 6.4.1. Dried Blood Spot 6.4.2. Hearing Screening 6.4.3. Critical Congenital Heart Defect (CCHD) 6.4.4. Other Test Types Chapter 7. Global Newborn Screening Market , by End user 7.1. Market Snapshot 7.2. Global Newborn Screening Market by End user, Performance - Potential Analysis 7.3. Global Newborn Screening Market Estimates & Forecasts by End user 2018-2027 (USD Billion) 7.4. Newborn Screening Market , Sub Segment Analysis 7.4.1. Hospitals 7.4.2. Diagnostic Centers 7.4.3. Other End Users Chapter 8. Global Newborn Screening Market , Regional Analysis 8.1. Newborn Screening Market , Regional Market Snapshot 8.2. North America Newborn Screening Market 8.2.1. U.S. Newborn Screening Market 188.8.131.52. Technology breakdown estimates & forecasts, 2018-2027 184.108.40.206. Test Type breakdown estimates & forecasts, 2018-2027 220.127.116.11. End user breakdown estimates & forecasts, 2018-2027 8.2.2. Canada Newborn Screening Market 8.3. Europe Newborn Screening Market Snapshot 8.3.1. U.K. Newborn Screening Market 8.3.2. Germany Newborn Screening Market 8.3.3. France Newborn Screening Market 8.3.4. Spain Newborn Screening Market 8.3.5. Italy Newborn Screening Market 8.3.6. Rest of Europe Newborn Screening Market 8.4. Asia-Pacific Newborn Screening Market Snapshot 8.4.1. China Newborn Screening Market 8.4.2. India Newborn Screening Market 8.4.3. Japan Newborn Screening Market 8.4.4. Australia Newborn Screening Market 8.4.5. South Korea Newborn Screening Market 8.4.6. Rest of Asia Pacific Newborn Screening Market 8.5. Latin America Newborn Screening Market Snapshot 8.5.1. Brazil Newborn Screening Market 8.5.2. Mexico Newborn Screening Market 8.6. Rest of The World Newborn Screening Market Chapter 9. Competitive Intelligence 9.1. Top Market Strategies 9.2. Company Profiles 9.2.1. Bio-Rad Laboratories Inc. 18.104.22.168. Key Information 22.214.171.124. Overview 126.96.36.199. Financial (Subject to Data Availability) 188.8.131.52. Product Summary 184.108.40.206. Recent Developments 9.2.2. GE Healthcare 9.2.3. Masimo Corporation 9.2.4. Medtronic Inc. 9.2.5. Natus Medical Incorporated 9.2.6. PerkinElmer Inc. 9.2.7. Trivitron Healthcare 9.2.8. ZenTech SA 9.2.9. Waters Corporation 9.2.10. Thermo Fisher Scientific Chapter 10. Research Process 10.1. Research Process 10.1.1. Data Mining 10.1.2. Analysis 10.1.3. Market Estimation 10.1.4. Validation 10.1.5. Publishing 10.2. Research Attributes 10.3. Research Assumption
Global Newborn Screening Market is valued at approximately USD 0.8 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 8.3 % over the forecast period 2021-2027. In recent years, the prevalence of fetal diseases has increased, leading healthcare providers to raise awareness and promote the need for innovative screening tools. The most common newborn defects are hearing, metabolic, and hormonal disorders, as well as critical congenital heart disease, all of which are treatable if detected early. According to the US CDC, the prevalence of newborn diseases in the United States was 34 per 10,000 live births between 2015 and 2017. Per year, about 12,900 babies are predicted to be diagnosed with a condition. Hearing deficiency (16.5 per 10,000), congenital hypothyroidism (6.0 per 10,000), sickle-cell disease (4.9 per 10,000), and cystic fibrosis are some other common diseases, according to the same source (1.8 per 10,000). Similarly, congenital heart disease affects 9 out of every 1,000 children, overall 200,000 children a year, according to the Indian Pediatric Academy. Due to their high birth rates and rising disposable income, India, China, and Brazil provide major opportunities to players. According to the United Nations Children’s Fund, India has 25 million births per year, accounting for almost one-fifth of all births worldwide. Because of the high birth rate and the provision of newborn screening in public hospitals, market products and consumables are in high demand. However, the availability of refurbished products may impede market growth over the forecast period of 2021-2027.
The regional analysis of the global Newborn Screening Market is considered for the key regions such as Asia Pacific, Europe, North America, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share due to availability of newborn screening programs, favorable reimbursement policies, and a strong market player presence in the region. Whereas Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027 due to increasing screening rate, and rising awareness regarding early diagnosis across APAC.
Major market player included in this report are:
Bio-Rad Laboratories Inc.
Natus Medical Incorporated
Thermo Fisher Scientific
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Tandem Mass Spectrometry
Enzyme Based Assays
By Test Type:
Dried Blood Spot
Critical Congenital Heart Defect (CCHD)
Other Test Types
By End user:
Other End Users
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018-19
Base year – 2019-2020
Forecast period – 2021 to 2027.
Target Audience of the Global Newborn Screening Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers